Brazil is one of the countries that carry out cesarean delivery in the world. The pain after cesarean delivery (CD) is one of the main concerns of parturient. Intrathecal Morphine (ITM) is widely used for the treatment of pain after CD; however, the optimal dose with minimal side effects is to be established. Objectives: To compare the analgesia and side effects resulted by three different doses of ITM as part of a multimodal regimen for postcesarean delivery analgesia. Methods: One hundred ninety-four patients were sampled in this randomized, double-blinded, three-arm study (group 0.075: ITM 0.75 mg; group 0.1: ITM 0.1 mg and group 0.15: ITM 0.15 mg). All patients received intravenous dexamethasone, dipyrone and ketoprofen. The primary endpoint was pain intensity measured at rest and on movement, while the secondary endpoint was overall satisfaction with pain relief, the incidence of nausea and vomiting, intensity of pruritus, and the use of additional tramadol, antipruritic and antiemetic use within 24 hours after postoperation. Results: The three groups showed similar pain intensity at rest and on movement. The pain intensity on movement was significantly higher than at rest in the groups (p < 0.001). There were no significant differences among the groups regarding secondary endpoint. Conclusions: Our findings suggest that in cases of an elective CD, 0.075 mg of ITM produces postoperative analgesia of similar quality that provided by 0.1 or 0.15 mg ITM. The patients should have a multimodal analgesia approach that includes: ITM, anti-inflammatory agents and access to additional systemic analgesic if necessary.
Introduction
The cesarean delivery (CD) rate has been increased in Brazil, reaching 55.5% in 2015 (around 1.8 million operations) [1] , which puts Brazil as one of the countries that carry out cesarean delivery in the world [2] .
The spinal anesthesia is the anesthetic technique most often used in elective CD or emergency situations [3] . Spinal anesthesia offers many advantages for the CD, due to the simplicity of technique, the speed in the administration, to have a fast onset of action and produce intense sensorial and motor neural blockade [4] . The bupivacaine is the local anesthetic of choice [5] . Because of the application of small dose, there is little risk of toxicity by anesthetic for pregnant and drug transfer to the fetus. Besides, the failure of the blockade and the need for conversion to general anesthesia is infrequent [6] .
The pain in postoperative CD is one of the main concerns of women [7] . Intrathecal Morphine (ITM) is widely used for the treatment of pain after CD [3] [8]. After administration, it has a slow onset of action and long duration of action (12 to 48 h) [9] . In particular, ITM leads to significant cost savings for the first 24 hours when compared with intravenous opioid patient-controlled analgesia [10] . A large part of the studies found in the literature, using ITM doses ranging from 0.1 to 0.25 mg [8] .
In our study, we use smaller doses of ITM between 0.07 and 0.08 mg, motivated by the concern that higher doses may increase the adverse effects such as nausea, vomiting, pruritus and especially respiratory depression because of the difficulty of monitoring by the nursing team after surgery [11] . However, it is possible that this practice does not provide adequate analgesia, given the observation that many mothers complained of pain of moderate to severe intensity, observed in a pilot study conducted recently in our study. The objective of this study is to compare the analgesia and side effects resulted by three different doses of ITM as part of a multimodal regimen for post-cesarean delivery analgesia. The primary endpoint of the study was the pain intensity measured at rest and on movement (moving from supine to sitting on the bed) at 6 hours and 24
Methods
hours. The pain intensity was reported by the patient using an 11-point numeric rating scale (NRS) with the anchors "no pain" = 0 and "worst pain ever" = 10 [13] . Secondary endpoint was tramadol use; the overall satisfaction with pain relief was assessed as 0 = very unsatisfied, 1 = unsatisfied, 2 = satisfied, or 3=very satisfied; pruritus was assessed using a 4 point score: 0 = absent, 1 = mild pruritus, 2 = moderate pruritus, or 3 = severe pruritus; incidence of PONV, antiemetic and antipruritic would be used within 24 hours.
Sample size calculations were based on data (4.8 mean ± 2.8 standard deviation pain scores on movement) from a pilot study involving ITM after CD. We considered a reduction in the mean intensity pain score of 1.8 mm as clinically significant. A sample size analysis, using 2-tailed Student t-test with power = 0.9 and α = 0.05 estimated a sample size of 51 per group.
The continuous data with normal distribution were analyzed by analysis of variance (ANOVA) followed by the Tukey test for post hoc analysis, if necessary.
The discrete or continuous data without normal distribution and ordinal data were analyzed by Kruskal-Wallis test followed by the Mann-Whitney test for post hoc analysis, if necessary. Comparison between two evaluations for quantitative variables was performed by using the non-parametric Wilcoxon's test (paired samples). For categorical data were used the Chi-square test to detect differences among groups and Fisher's exact test to detect the difference among the groups. For all analyses, the p-value was set at 0.05 for statistical significance.
Results
Two hundred and forty-three patients were sampled for the study. Two hundred and one patients were randomized to the study. Two patients in the group 0.075 were excluded due to loss of follow-up, one was excluded due to postoperative complication (abdominal wall hematoma) and another case for allergy to ketoprofen (angioedema). Five patients were excluded due to data missing (three patients in the group 0.15, one in the group 0.01 and, another in the group 0.075). The flow chart of recruitment, allocation, follow-up, analysis of patients, and causes of exclusion is shown in Figure 1 .
The groups were homogeneous regarding age, body mass index, ASA physical status class, parity, gestational age, previous CD and fentanyl use during surgery and duration of operation ( Table 1 ).
The three groups showed similar pain intensity at rest and on movement, in 6 hours and 24 hours postoperatively. The pain intensity on movement was significantly higher than at rest in the groups (p < 0.001, Wilcoxon's test). There were no statistical differences among groups regarding tramadol use. The overall satisfaction (satisfied/very) with control relief was 73.8%, 82.5% and 87.8% in Open Journal of Obstetrics and Gynecology the groups 0.075, 0.1 and 0.15, respectively. However there were no significant differences among the groups (Table 2 ).
There was no significant difference for the incidence of nausea among dose The moderate to severe pruritus were progressively higher: group 0.075 (13.8%), group 0.1 (20.5%) and group 0.15 (24.1%) as the intrathecal doses of morphine increased, but there were no significant differences (Table 3) . None of the patients suffered from respiratory depressions in this study.
Discussion
ITM has been widely used for analgesia after CD because of its prolonged [3] . However, intrathecal opioids might result in side effects such as nausea, vomiting, pruritus, sedation, and respiratory depression [11] . In the context, the promotion of adequate analgesia with minimal side effects is essential in obstetrics.
The pain assessment is complex and concerns the influences of emotional factors, cognitive, cultural, and ethnic. The well-known visual analog scale (VAS) and numeric rating scale (NRS) for assessment of pain intensity agree well and are equally sensitive in assessing acute pain after surgery. The NRS is more practical than a VAS and easier to understand for the most people and taking into account that acute pain during movement (dynamic pain) is more important than pain at rest. Therefore, we use the NRS as a method of evaluation of pain at rest and on movement in this study [13] . mg prophylactic ondansetron had an incidence of 8% of PONV, whereas those receiving placebo the incidence was 56% [21] . While Imeh et al. found an incidence of 9.3% and 37% of PONV when they used dexamethasone plus ondansetron prophylactically compared to dexamethasone in patients who received 0.2 mg of ITM [22] . In our study, the incidence of PONV was low in three groups:12.2%, 15.7% and 15%, probably the use of dexamethasone and ondansetron may have contributed favorably to these results.
Spinal opioid-induced pruritus is an unwanted pruritus sensation that is often seen in obstetric patients with an incidence of 20% to 100% [23] . In the meta-analysis performed by George et al. the use of prophylactic 5-HT3 receptor antagonists were ineffective in reducing the incidence of pruritus, but they greatly reduced the severity and the need for treatment of pruritus [24] . Recently two papers has been published which analyzed the use of prophylactic ondansetron in parturients, and showed conflicting results. In one study, pruritus was reduced by 72%, while in another study there was no reduction in pruritus, both compared to placebo [21] [25]. In our study, there were no differences in the incidence of pruritus and use of antipruritic medication (promethazine). It was observed that an incidence of pruritus around 60%, but the intensity (moderate to severe) of the pruritus was low, ranging from 14% to 24% in the groups. Also, less than 8% of patients requested antipruritic medication.
Limitations of the study: the study was conducted at a single center and involved a relatively small number of patients; this may impact on the generalizability of the results of this study. The calculation of the power of the current study was based on a pilot study and not a large randomized clinical trial. The use of tramadol as an analgesic rescue (important secondary endpoint) via PCA could better reflect the consumption of this painkiller.
Conclusion
In conclusion, we compared results when 0.075, 0.1 or 015 mg of ITM was added to hyperbaric bupivacaine 12.5 mg. Our findings show that in cases of the elective CD, 0.075 mg of ITM produces postoperative analgesia of similar quality that provided by 0.1 or 0.15 mg ITM with no difference in the IV tramadol use, overall satisfaction with pain relief and side effects. However, the pain scores on movement were higher than at rest in 6 hours and 24 hours in the three groups.
Despite of several results of different studies on the doses of morphine for analgesia, there is no recommendation for the optimal dose of ITM which produces Open Journal of Obstetrics and Gynecology adequate analgesia with minimal side effects. Therefore the patients who submitted the CD should have a multimodal analgesia approach that includes: ITM, anti-inflammatory agents and access to additional systemic analgesic if necessary because a portion of patients may feel moderate to severe pain, especially on movement.
